BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10531415)

  • 1. N-linked glycosylation is required for plasma membrane localization of D5, but not D1, dopamine receptors in transfected mammalian cells.
    Karpa KD; Lidow MS; Pickering MT; Levenson R; Bergson C
    Mol Pharmacol; 1999 Nov; 56(5):1071-8. PubMed ID: 10531415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing the constitutive activity among dopamine D1 and D5 receptors and their mutants.
    Plouffe B; D'Aoust JP; Laquerre V; Liang B; Tiberi M
    Methods Enzymol; 2010; 484():295-328. PubMed ID: 21036239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of human D1 and D5 dopaminergic G protein-coupled receptors: lessons from mutagenesis of a conserved serine residue in the cytosolic end of transmembrane region 6.
    Plouffe B; Tiberi M
    Methods Mol Biol; 2013; 964():141-80. PubMed ID: 23296783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine D5 receptor agonist high affinity and constitutive activity profile conferred by carboxyl-terminal tail sequence.
    Demchyshyn LL; McConkey F; Niznik HB
    J Biol Chem; 2000 Aug; 275(31):23446-55. PubMed ID: 10807903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential distributions and trafficking properties of dopamine D1 and D5 receptors in nerve cells.
    He Y; Yu LP; Jin GZ
    Neurosci Bull; 2009 Apr; 25(2):43-53. PubMed ID: 19290022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of human dopamine D1-like receptor agonist using a cell-based functional assay.
    Jiang N; Ou-Yang KQ; Cai SX; Hu YH; Xu ZL
    Acta Pharmacol Sin; 2005 Oct; 26(10):1181-6. PubMed ID: 16174433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photoaffinity labeling of D1 and D5 dopamine receptors.
    Sidhu A; Banta M; Uh M; Shin Y
    Neuroscience; 1998 Feb; 82(4):1095-101. PubMed ID: 9466433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the role of N-glycosylation in cell-surface expression and binding properties of angiotensin II type-2 receptor of rat pheochromocytoma cells.
    Servant G; Dudley DT; Escher E; Guillemette G
    Biochem J; 1996 Jan; 313 ( Pt 1)(Pt 1):297-304. PubMed ID: 8546698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-linked glycosylation of the human Ca2+ receptor is essential for its expression at the cell surface.
    Fan G; Goldsmith PK; Collins R; Dunn CK; Krapcho KJ; Rogers KV; Spiegel AM
    Endocrinology; 1997 May; 138(5):1916-22. PubMed ID: 9112387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MS Binding Assays for D1 and D5 Dopamine Receptors.
    Neiens P; Höfner G; Wanner KT
    ChemMedChem; 2015 Nov; 10(11):1924-31. PubMed ID: 26332653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the extracellular amino terminus and first membrane-spanning helix of dopamine D1 and D5 receptors in shaping ligand selectivity and efficacy.
    D'Aoust JP; Tiberi M
    Cell Signal; 2010 Jan; 22(1):106-16. PubMed ID: 19786093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coupling of D1 and D5 dopamine receptors to multiple G proteins: Implications for understanding the diversity in receptor-G protein coupling.
    Sidhu A
    Mol Neurobiol; 1998 Apr; 16(2):125-34. PubMed ID: 9588624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of Endocannabinoid-Binding Receptors in Human Neuroblastoma Cells by Tunicamycin.
    Rapino C; Castellucci A; Lizzi AR; Sabatucci A; Angelucci CB; Tortolani D; Rossi G; D'Andrea G; Maccarrone M
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30979007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that stimulatory dopamine receptors may be involved in the regulation of prolactin secretion.
    Porter TE; Grandy D; Bunzow J; Wiles CD; Civelli O; Frawley LS
    Endocrinology; 1994 Mar; 134(3):1263-8. PubMed ID: 8119166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylphenidate amplifies long-term potentiation in rat hippocampus CA1 area involving the insertion of AMPA receptors by activation of β-adrenergic and D1/D5 receptors.
    Rozas C; Carvallo C; Contreras D; Carreño M; Ugarte G; Delgado R; Zeise ML; Morales B
    Neuropharmacology; 2015 Dec; 99():15-27. PubMed ID: 26165920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D1A, D1B, and D1C dopamine receptors from Xenopus laevis.
    Sugamori KS; Demchyshyn LL; Chung M; Niznik HB
    Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10536-40. PubMed ID: 7937989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galpha12- and Galpha13-protein subunit linkage of D5 dopamine receptors in the nephron.
    Zheng S; Yu P; Zeng C; Wang Z; Yang Z; Andrews PM; Felder RA; Jose PA
    Hypertension; 2003 Mar; 41(3):604-10. PubMed ID: 12623966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct function of the cytoplasmic tail in human D1-like receptor ligand binding and coupling.
    Jackson A; Iwasiow RM; Tiberi M
    FEBS Lett; 2000 Mar; 470(2):183-8. PubMed ID: 10734231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three putative N-glycosylation sites within the murine 5-HT3A receptor sequence affect plasma membrane targeting, ligand binding, and calcium influx in heterologous mammalian cells.
    Quirk PL; Rao S; Roth BL; Siegel RE
    J Neurosci Res; 2004 Aug; 77(4):498-506. PubMed ID: 15264219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional D1 and D5 dopamine receptors are expressed in the suprachiasmatic, supraoptic, and paraventricular nuclei of primates.
    Rivkees SA; Lachowicz JE
    Synapse; 1997 May; 26(1):1-10. PubMed ID: 9097400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.